Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
44,400,171
-
Share change
-
+27,579,306
-
Total reported value
-
$117,660,809
-
Put/Call ratio
-
79%
-
Price per share
-
$2.65
-
Number of holders
-
73
-
Value change
-
+$75,460,214
-
Number of buys
-
51
-
Number of sells
-
14
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q4 2024
As of 31 Dec 2024,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,400,171 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., Privium Fund Management B.V., Woodline Partners LP, MILLENNIUM MANAGEMENT LLC, Affinity Asset Advisors, LLC, UBS Group AG, Sio Capital Management, LLC, Kynam Capital Management, LP, Siren, L.L.C., and DAFNA Capital Management LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.